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Abstract 
Background: Diabetes mellitus is the leading cause of chronic kidney disease (CKD) requiring 
dialysis and contributes to one-half of all new dialysis cases each year in Canada.  Despite the 
ability to stop or slow the progression of CKD through early detection and intervention, CKD 
continues to rise, in part, due to providers’ lack of knowledge of and adherence to established na-
tional clinical practice guidelines (CPGs).  Methods: A quality improvement project was imple-
mented in a rural, primary care clinic to enhance provider knowledge of the current CPG recom-
mendations for CKD screening before and after a provider-specific educational intervention.  Re-
sults: The educational intervention improved provider knowledge of and confidence in screening 
for renal disease in diabetic patients. The average numbers of diabetic patients screened for renal 
disease improved each year, with 85.5% being screened in 2015-2016, resulting in a net increase 
of 31.5%.  In addition, modifiable risk factor screening by providers also improved in the same 
period, including measures of weight, blood pressure, lipids, and glycosylated hemoglobin lev-
els.   Conclusion: Increasing primary provider awareness and knowledge, through education, can 
foster early recognition and management of CKD in diabetes and ultimately improve renal health 
outcomes in the diabetic population.   
Keywords:     Type 2 diabetes, chronic kidney disease, primary care, provider adherence, 
clinical practice guidelines, quality improvement
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Primary Care Provider Adherence to the Canadian Diabetes Association Guideline  
for Chronic Kidney Disease 
The rapidly increasing rate of diabetes mellitus has become a major public health issue 
worldwide with latest estimates identifying 9% of the global population affected by the disease 
(World Health Organization, 2014).  In Canada, rates are slightly higher, with 9.4% (3.4 million) 
of the population having diabetes (Canadian Diabetes Association [CDA], 2015).  Improved 
therapies have increased life expectancy, and, subsequently, amplified the incidence of sequelae, 
including progressive kidney failure and chronic kidney disease (CKD) (Lloyd & Komenda, 
2015; Packham, et al., 2012).  Diabetes is the leading cause of kidney failure requiring dialysis 
and contributes to one-half of all new dialysis cases each year (CDA, 2013; Canadian Institute 
for Health information [CIHI], 2012; Public Health Agency of Canada, 2011).  Further, studies 
show that 50% of diabetics will demonstrate renal markers of kidney damage, also known as dia-
betic nephropathy, in their lifetime (CDA, 2013).  Diabetes-related CKD has significant individ-
ual and societal costs impacting mortality, patient quality of life and healthcare system costs 
(CDA, 2013; CIHI, 2009; McFarlane, Gilbert, MacCallum & Senior, 2015; Nova Scotia Renal 
Program, 2015; Pyram, Kansara, Banerji & Loney-Hutchinson, 2011).  
Comprehensive clinical practice guidelines (CPGs) for the prevention and management 
of diabetes and related co-morbidities, including chronic kidney disease, have been developed by 
the Canadian Diabetes Association.  These guidelines, developed by an expert panel using peer-
reviewed evidence, have been recognized nationally and internationally as being rigorous and of 
high quality (CDA, 2013) (Appendix A).  However, there has been varied success in the uptake 
of and adherence to renal protective recommendations by primary care providers (PCPs) which 
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has contributed to a delay in the early detection and management of diabetes-related chronic kid-
ney disease (CDA, 2013; CIHI, 2009, 2012; Eilat-Tsanani, et al, 2014; Kastner, et al., 2015; 
Malcolm, et al., 2013). 
Problem Statement 
 Screening for early chronic kidney disease by primary care providers, using the Canadian 
Diabetes Association guideline, is part of the nationally recommended management of the dia-
betic patient to achieve optimal renal health (CDA, 2013).  However, there has been varied suc-
cess in the uptake and adherence to the CDA guidelines by PCPs to prevent and manage chronic 
kidney disease.  Prevention and at a minimum early detection of clinically-significant changes in 
renal function can lead to early intervention and potentially delay the progression of renal dis-
ease.  Increasing PCPs knowledge of these guidelines has the potential to increase adherence and 
lead to earlier detection and management of CKD to slow or even halt its development and pro-
gression.   
Review of the Literature 
This review was conducted using the Cumulative Index to Nursing and Allied Health Lit-
erature (CINAHL), PubMed, and Medline, utilizing the Medical Subject Headings (MeSH) of 
“type 2 diabetes,” “chronic kidney disease,” “primary care providers,” “clinical practice guide-
lines,” and “adherence.”  Initial inclusion criteria consisted of articles that focused on PCP adher-
ence to diabetes-related renal guidelines in primary care that were published in peer-reviewed, 
English-language journals within the preceding five years (i.e., 2011-2016).  Exclusion criteria 
included commentary and opinion articles and studies of late chronic renal disease involving re-
nal dialysis, where early detection is no longer applicable.  As there was extreme paucity of re-
search specific to these criteria, the search was expanded to include general studies surrounding 
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adherence to CPGs in primary care, as well as older publications having relevant content and sig-
nificant findings. 
Clinical Practice Guidelines Adherence 
Clinical practice guidelines are developed to assist providers in clinical decision-making 
by providing evidenced-based care pathways on up-to-date therapies and interventions, with the 
overall aim to reduce inappropriate patient harm and improve patient outcomes (Pronovost, 
2013).  Given the large number of CPGs to guide primary care practice, it is extremely challeng-
ing for providers to be aware of all evidence aimed at improving practice.  Even when aware, be-
coming familiar and knowledgeable of CPGs is not guaranteed, which can negatively influence 
provider behavior in adopting and adhering to CPGs.  
Throughout the literature, there has been a multitude of barriers to providers’ adoption of 
and adherence to CPGs, including environmental, professional practice, guideline-specific, and 
behavioral factors (Abdel-Kader, et al., 2014; Cabana, 1999; Ennis, et al., 2015; Fox, et al., 2013; 
Kortteisto et al., 2010; Lutenberg, Burgers, Besters, Han & Westert, 2011; Szczech, et al., 2014; 
Taba, et al., 2012).  Provider barriers are widely varied and include such factors as limited 
knowledge and lack of familiarity with the CPG, skepticism about the value and use of CPGs, 
and shortage of both time and resources with which to implement (Ennis et al., 2015; Kilpatrick, 
Pichette & Jabbour, 2014; Taba et al, 2012).  To better understand these influences, the work of 
Cabana (1999) will be referenced, which separates barriers into three domains having the most 
significant influence on adherence to CPGs, namely provider knowledge, attitudes, and behavior.   
Provider knowledge.  Several knowledge-based factors on impacting the uptake of 
CPGs were identified in the literature, including PCP degree of familiarity with guidelines and 
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quality indicators.   Given the large number of CPGs to guide primary care practice, it is ex-
tremely challenging for providers to be aware of all the evidence aimed at improving practice; 
even with awareness, becoming familiar and knowledgeable of CPGs is not guaranteed.  PCPs 
who valued the use of CPGs related to CKD identified general lack knowledge and expertise on 
how to diagnose and manage CKD and were less familiar with specific measures which indicated 
renal abnormalities (Abdel-Kader, et al., 2014; Crinson, Gallagher, Thomas & de Lusignan, 
2010).  Those parameters familiar to general practitioners (i.e., measures of blood pressure and 
glycosylated hemoglobin testing), were measured and treated at a higher rate compared to those 
that were not well-known (i.e., kidney-related management activities, including nephrology re-
ferral for proteinuria) (Eilat-Tsanani et al., 2014).   
Provider attitude.  Attitudinal barriers relate to the way providers perceive the content 
and applicability of guidelines, as well as personal belief in the ability to implement the guideline 
and maintain a practice change (Cabana, 1999; Crinson et al., 2010).  In their work, Lugtenberg, 
Zegers-van Schaick, Westert and Burgers (2009) identified lack of agreement with a guideline, 
due to lack of evidence or lack of applicability to the patient, as the most significant barrier to 
provider adherence.  Other researchers found more significant differences in uptake and adher-
ence based on years of primary care provider clinical experience, in that providers practicing in 
outpatient setting or for more than 25 years were the most likely group to have difficulty using 
guidelines, although most denied that guidelines were too complex or difficult to access (Taba, et 
al., 2012). 
Provider behavior.  Behavioural barriers include external factors largely out of the per-
ceived control of the provider, such as guideline-related, patient-related, environmental issues 
(i.e., lack of time, human, and financial resources).  Lack of time was the most common barrier 
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to lack of use of CPGs, followed by lack of medical resources needed to implement the guideline 
(Abdel-Kader, et al., 2014; Taba, et al, 2012).  Primary care providers also expressed concerns 
assigning a diagnosis of CKD using one specific measure (i.e., eGFR), the potential psychologi-
cal impact of CKD diagnosis on patients, and difficulty in approaching patients to explain CKD 
(Crinson et al., 2010). 
Approaches to Improve Adherence 
To address the challenges and barriers to integrating CPGs by primary care providers, ap-
proaches and models of care have been proposed and trialed throughout the literature.  The fol-
lowing is a brief review of literature surrounding these interventions related to CKD. 
Alternate care providers.  Methods to improve uptake of CPGs have involved integra-
tion of other health professionals in CKD care delivery, albeit with varied success.  Researches 
have sought to improve renal outcomes with the addition of advanced practice professionals (i.e., 
advanced practice nurses/nurse practitioners) to the routine care provided by physicians (Barrett, 
et al., 2011; Peeters, et al., 2014).  While studies have supported that the use of a multifactorial 
intervention directed at multiple treatment targets, the effect was only modest in improving renal 
outcomes and reducing renal decline.  Further, the use of a nurse-led team did not significantly 
affect the rate of decline in kidney function or provide control of CV risk factors when compared 
to the findings from the control groups receiving usual care across the studies. 
Clinical processes and tools.  Other approaches have involved modification of clinical 
processes and introduction of clinical tools to improve efficiency, work flow, and team work.  
One group sought to improve adherence to evidence-based care pathways for patients with dia-
betes and CKD by developing a framework that included six team processes proposed to be im-
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proved by the additional of a nurse practitioner, which included communication, decision-mak-
ing, cohesion, problem-solving, care coordination and focus on patients and families (Kilpatrick 
et al., 2014).  Results supported several strategies that helped in integrating CPGs, including de-
velopment of complementary roles within the team, actively involving patients in their care, us-
ing EBP guidelines adapted to individual patients, communication, and coordination of complex 
care.    
To improve efficiency, other methods have focused on implementing clinical protocols, 
tools and flowsheets.  Researchers introduced several interventions to improve adherence to CPG 
in managing diabetes compare to usual clinical care, including increasing appointment time, cre-
ating patient reminders, and use of a standardized diabetic flow sheet (Lin, Haler & Kirby, 2007).  
These results showed an improvement in clinically significant outcome measures, in addition, the 
interventions proved easy to implement and supported improved clinical outcomes.    
These studies demonstrated improved renal outcomes with the addition of other health 
professionals and highlighted the importance of team processes in improving communication, 
decision-making, cohesion, problem-solving, care coordination and focus on patients and fami-
lies (Kilpatrick et al., 2014).  Strategies that helped the integration of CPGs included develop-
ment of complementary roles within the team, actively involving patients in their care, using evi-
dence-based practice guidelines adapted to individual patients, enhancing communication, and 
coordinating complex care (Lin et al., 2007; Peeters et al., 2014).  Other clinical models and pro-
cesses have been developed increase screening and improve quality outcome measures support-
ing the use of a multimodal approach to screening for CKD.  Studies in this area have identified 
the importance of both a multidisciplinary team approach and use of specific clinical protocols in 
improving health outcomes (Ennis, et al., 2015).  Still others focus refining processes, such as 
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utilizing specific clinical protocols and flowsheets to improve efficiency and quality outcomes in 
renal diabetes care.   
The importance of quality initiatives to improve diabetes management via primary care 
clinics cannot be overstated, yet remains a challenge for providers.  Review of the research iden-
tified several methods with which to negate the many obstacles encountered by PCPs in screen-
ing for CKD in diabetes, including lack of provider time.  Also recognized are process barriers, 
such as financial and time constraints, and lack of key persons to coordinate or drive this work.  
Numerous clinical models and processes have been developed that are directed at increasing 
screening and improving quality measures with more recent evidence supporting the use of a 
multimodal approach to screening for CKD.  Newer models include integration of advanced 
practice nurses and other health professionals to lead the change process; other models focus on 
refining processes, such as utilizing specific clinical protocols and flowsheets, to improve effi-
ciency and, ultimately, quality outcomes.  Incorporation of CPGs specific to screening for CKD 
in diabetes using established flowsheets and protocols provides a fitting and appropriate frame-
work for continuous quality improvement and evaluation of provider processes and patient out-
comes.   
Theoretical Framework 
The Theory of Planned Behavior (TPB) provided the foundation for the design of this cap-
stone project (Appendix B).  It has been used throughout the literature with health care providers 
to better understand the influences on behavior change, including attitudes and beliefs around 
adoption and use of clinical practice guidelines (Ceccato, Ferris, Manuel & Grimshaw, 2007; 
Kortteisto, Kaila, Komulainen, Mantyranta & Rissanen, 2010).  The premise of the TPB is that 
the constructs of personal attitudes, social norms, perceived behavioral control, and behavioral 
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intention are all influencing factors on behavior change, the greatest of which is intention (Ajzen, 
1991).  The theory proposes that the three concepts of: 1) intention (i.e., personal attitude to-
wards the behavior), 2) subjective norm (i.e., social pressure and normative beliefs about the be-
havior), and 3) perceived behavioral control (i.e., ability to control and perform the behavior) 
combine to determine the strength of the intention to perform the behavior.  By using this model 
to underpin this project, it is projected that there will be an improved understanding of influences 
on provider behavior to use CPGs as well as identification of factors to improve adherence. 
Project Design and Methods 
Goals, Objectives, and Expected Outcomes 
 The goal of this project was to improve provider rates of screening for early chronic kid-
ney disease in diabetics.  To achieve this, this capstone project aimed to increase provider 
knowledge and awareness, through education, of nationally-established clinical practice guide-
lines that detailed the parameters for renal screening and reassessment in diabetics.  Expected 
outcomes included increased provider awareness of and adherence to the renal-diabetes CPG as 
well as improvement in the numbers of diabetic patients screened for CKD using recommended 
screening tests. Secondary outcomes were evaluated using the reporting system of the electronic 
medical record (EMR) database.  With assistance from the provincial EMR data analyst, data 
were generated on numbers of diabetic patients screened with estimated glomerular filtration rate 
(eGFR), creatinine, albumin-creatinine ratio (ACR) or urine for microalbumin (MAU) in the 
three-year period from 2014 through 2016 preceding implementation of this project.  This infor-
mation was used to compare the effectiveness of the project educational intervention on improv-
ing provider screening practices.   
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Setting and Resources 
This project was implemented in a small, rural primary health care clinic in Guysborough 
township located in Guysborough County, the largest and most geographically dispersed county 
in the province of Nova Scotia, Canada.  A large proportion of patients registered with the clinic 
are elderly with limited income and resources.  There are also three surrounding communities of 
African Nova Scotians, who are at increased risk for diabetes due to their ethnicity and the co-
morbid condition of CKD.    
Description of the group, population or community.  The project participants con-
sisted of the primary health care collaborative practice team, comprised of two family practice 
physicians, one family nurse practitioner, and the diabetes education team (i.e., registered nurse 
and registered dietitian) who work closely with the collaborative team in providing diabetes-spe-
cific care.   
The patient population was comprised of all adult Type 2 diabetics ages eighteen and 
older who received care from the collaborative care team physicians.  All patients presenting for 
a clinical appointment who had not received renal screening in the past twelve months were eli-
gible for screening, consisting of a measure of estimated glomerular filtration rate (eGFR), serum 
creatinine, microalbuminuria (MAU), or albumin-creatinine ratio (ACR). 
 Organizational analysis of project site.  Prior to implementing this project, an informal 
review of the electronic medical records of a random selection of twenty-five adult diabetic pa-
tients under the care of the two primary care providers was conducted.  From this data, a random 
review of laboratory results was reviewed to determine the extent to which renal laboratory 
screening was completed.  This review included both the type of renal laboratory testing as well 
as the frequency and accuracy of repeated screening.  The information obtained from this review 
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provided support for the project as less than 52% of this select group of patients had electronic 
documentation of renal screening in the previous year (i.e., 2013-2014).  Fewer still had repeat 
laboratory measures within the recommended time frame or at all.  Data generated from the 
EMR by the provincial data analyst supported this conclusion finding that on average only 54% 
of diabetic patients were screened for renal measures during that time.   
 Primary health care team members recognized the need for continuous quality improve-
ment in delivery of renal-diabetes care and were instrumental in early discussions on improving 
individual and group clinical screening practices.  To promote engagement and to standardize the 
approach across all providers, clinical practice guidelines on the screening, detection, monitoring 
and treatment of chronic kidney disease in diabetes as well as the provincial guidelines from the 
Nova Scotia Renal Program (Province of Nova Scotia, 2013) were shared with primary care pro-
viders through a nationally-developed PowerPoint presentation (CDA, 2015).  Providers were 
encouraged to hold discussions with diabetic patients during their regular appointment times to 
inform them of the recommendation for renal screening as part of routine diabetes care.  A bro-
chure on the importance of awareness and monitoring of renal health in diabetes was made avail-
able to providers to be shared with patients.   
To evaluate intervention success, the provider questionnaire was administered immedi-
ately prior to and one week after delivery of the educational intervention.  There was a total of 26 
questions - the first 17 questions measured provider confidence in (1) knowledge of the renal 
screening guideline, and (2) ability to apply the guideline in clinical practice.  An additional nine 
questions evaluated specific knowledge components of the guideline. 
 Evidence of stakeholder support.  This project received wide-reaching stakeholder sup-
port, not only from the primary care collaborative physician group who recognized the clinical 
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benefits of the project to their practice and their patients, but also from both the Nova Scotia 
Eastern Health Authority Zone Primary Health Care Manager and Director.    
Implementation.  A pre-project questionnaire was administered to the providers and dia-
betes educators to gauge the level of knowledge of the most recent clinical practice guideline as 
well as their confidence in integrating the recommendations into practice (Appendix C).  An edu-
cational intervention, consisting of a thorough review of the clinical practice guideline on screen-
ing for, and management of, CKD using a nationally-prepared and approved presentation (CDA, 
2015), was then delivered.  This presentation was supplemented with a provider toolkit contain-
ing nationally-recognized print resources for quick reference during patient appointments.  
Toolkit items included: 1) the complete Clinical Practice Guideline for Chronic Kidney Disease 
(2013), 2) Guideline for Therapeutic Management of Diabetic Medications in CKD, 3) the Nova 
Scotia Renal Program Guideline (2016) (including laminated poster for office reference), and 4) 
a patient education pamphlet outlining the importance of routine renal screening in diabetes 
(Kidney Foundation of Canada, 2009) (Appendix D).  Post completion of the educational inter-
vention, the provider questionnaire was again administered to assess change in knowledge and 
intent to change practice behaviors.  The project was implemented over a 3-month period begin-
ning in October, 2016.  Data were extracted from the EMR at several points before, during and 
on completion of the project to assess for change in provider screening rates.   
Ethics and Human Subjects Protection 
A human subjects’ determination form was submitted to the UMASS IRB before begin-
ning the project to determine if IRB approval was necessary; additional review by the Nova Sco-
tia Health Authority Research Ethics Board was completed for similar determination.  Both enti-
ties concluded that as a quality improvement project, additional ethical review was not required.  
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Data collected from the patient EMR, including measures of renal function, were de-identified 
and analyzed in the aggregate in terms of overall rates to maintain patient confidentiality.  No 
other personal identifiers were linked to the extracted information.  To protect the identities of 
the individual providers, pre-and post-test questionnaires were assigned individual codes by an 
administrative support team member.  Any information used in the project was kept in a locked 
cabinet and only accessed by those directly involved in the project. 
Data Analysis 
 Pre- and post-intervention provider questionnaires were administered to four primary 
health care team members, including two family physicians, a dietitian, and a registered nurse.  
The latter two participants were diabetic educators directly involved in the care, education, and 
management of diabetic patients of the primary health care clinic.  Data from both the pre- and 
post-intervention questionnaires were used to determine change in providers’ knowledge of the 
CPG as well as confidence in using the recommended testing to evaluation renal function of their 
diabetic patients.  
 Information was extracted from the patient electronic medical records (N=163) to 
determine whether there had been a change in provider screening rates over time.  Screening for 
five modifiable risk factors in diabetes were included in this analysis, including blood pressure 
(BP), cholesterol levels/lipids, body weight/obesity), glycoslated hemoglobin/A1c,, and kidney 
function (renal lab values).   
Results 
 Data were analyzed using dependent group t-tests, to compare pre- and post-intervention 
knowledge scores.  Because of the small sample size, resulting in a low power, a one-tail test was 
completed.  Overall, findings demonstrated that there was a significant improvement (t(3) = 2.6, 
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p = 0.039) in provider knowledge of the clinical practice guideline before (M=2.3; SD=1.0) com-
pared to after (M=4.5; SD=1.7) the educational intervention.  Specifically, providers were more 
confident in using urine protein screening to manage their diabetic patients; more confident in 
identifying conditions that can cause transient albuminuria; more confident in identifying the 
stages of nephropathy using urinary albumin measures; and more confident in identifying non-
diabetic causes of CKD in diabetics (see Table 1). 
 
Table 1 Change in Provider Confidence Post-Questionnaire Results 
 Pre-
test  
Post-
test  
SD One-tailed 
p 
Knowledge of CPG 3.4 4.0 1.73 -2.6 
Use of Urine Protein Screening 3.0 3.8 .500 -3.0 
Identifying Causes of Transient Albuminuria 2.5 3.8 .957 -2.6 
Identifying Stages of Nephropathy 2.7 4.0 .957 -2.6 
Identifying non-diabetic causes of CKD 2.5 3.8 .957 -2.6 
     
 
 
To examine differences between provider type (i.e., physician, registered nurse, dietitian) 
in screening for the modifiable risk factors of blood pressure (BP), lipids, obesity, A1c and renal 
function, an independent t-test was conducted comparing physicians to non-physicians.  Results 
showed that there were no significant differences observed in rates of screening for any of the 
five modifiable risk factors by provider type. 
PRIMARY CARE PROVIDER ADHERENCE                                                                  18  
 
To examine changes in screening across time, several repeated measures ANOVAs were 
performed comparing the three years of screening rates from 2014 – 2016. Results identified 
changes in provider screening for modifiable risk factors over time.  Specifically, over time there 
was a significant increase in blood pressure screening (F=34.45; p=.0045) and measures of lipids 
(F=7.36; p=.035) (Figure 1).  However, while there was a modest improvement in provider 
screening for obesity (F=1.953; p=.143), glycolated hemoglobin (A1c) (F=1.785; p=.154), and 
renal measures (F=1.904; p=.146) over time, results did not reach statistically significance.   
 
Figure 1 Rates of Provider Screening for Modifiable Risk Factors 
 
 
 
One of the most important changes to note resulting from this project is the change in 
screening rates over the two-year period.  Prior to the project specific dates (Oct. – Dec. 2016), 
there were many team discussions regarding the proposed quality improvement initiative.  As a 
result of these discussions which increased provider awareness, the average numbers of diabetic 
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patients screened by providers for modifiable risk factors, including renal disease, improved in 
each consecutive year.  Specifically, overall rates of screening for CKD increased from 54% 
(2014) to 85.5% (2016), resulting in a net increase of 31.5%.  Rates of screening for other 
diabetic risk factors improved in the same time period, including measures of blood pressure, 
lipids, weight, and A1c (Table 2). 
 
Table 2 Average Screening Rates Over Time for Modifiable Risk Factors 
Year %BP %Lipids %Obesity %A1c %Renal 
      
2013-2014 29.0 49.5 14.5 23.7 54.0 
2014-2015 73.5 66.0 25.0 46.0 81.0 
2015-2016  92.2 69.5 40.5 67.0 85.5 
      
 
Facilitators and Barriers 
There were several facilitators that assisted with implementation of this project.  Primary 
care providers recognized the need to improve clinical practice in renal-diabetes care.  There 
were also other primary health care team members (i.e., nurse practitioner and diabetes educa-
tors), who were knowledgeable of diabetes and well-positioned to support the physicians in coor-
dinating patient follow-up.  These team members also had longer appointment times in which to 
complete more detailed patient chart reviews to identify whether renal screening and follow-up 
were up-to-date.  The project was implemented onsite within the existing clinic space during reg-
ularly scheduled appointment times; thus, there was not a significant increase in provider work 
demands, patient appointment times, or a notable impact on clinic processes. 
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There were several challenges in implementing this project.  In relation to work-flow, 
there was not a clinic-specific diabetic patient database in which to organize care or to track 
chronic disease management.  There was also significant variation in documentation and diag-
nostic coding in the electronic medical record (EMR) among providers, which created a chal-
lenge in collecting and analyzing data.  In relation to practice-based barriers, the project site was 
a busy primary health clinic servicing over 3000 patients, most of whom were elderly and who 
had multiple, complex comorbidities.  Large patient volumes and limited time allotted for ap-
pointments challenged providers to have ample time to educate patients on the importance of 
screening for CKD.  Limited clinical appointment time also challenged providers to retrospec-
tively review the renal history of diabetic patients to identify those at risk for progression of 
CKD and in need of further follow-up screening.  
Discussion 
 Screening for chronic kidney disease can help providers achieve optimal renal health for 
their diabetic patients.  The greatest barriers that prevent guidelines from being followed are lack 
of awareness of and familiarity with the guideline (Cabana, 1999; Ennis et al., 2015; Misra & 
Barth, 2016).  The goal of this project was to increase provider knowledge and awareness of na-
tional clinical practice guidelines so as to positively influence screening rates to ultimately delay 
or prevent chronic kidney disease.  Delivering an educational intervention aimed at increasing 
provider awareness of these evidence-based practice guidelines, including recommended labora-
tory tests, clinical parameters, and appropriate time-to-follow-up and referral to specialists, sig-
nificantly improved provider confidence in making clinical decisions in the care of diabetic pa-
tients.   
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The findings from this project underscore the importance of educational initiatives that 
promote positive change in provider clinical practice.  In comparing pre- and post-intervention 
questionnaire responses, providers demonstrated a significant improvement in confidence in (1) 
using recommended laboratory tests to manage the renal health of their diabetic patients, (2) in-
terpreting results of renal testing to appropriately manage their patients, (3) identifying stages of 
nephropathy, and (4) recognizing non-diabetic causes of CKD.  This may be attributed to an in-
crease in general knowledge of the specifics of the guideline including recommended laboratory 
tests and screening intervals for renal disease in diabetes.   
Also, it is important to note the continued increase over time in provider rates of screen-
ing for all five modifiable diabetes risk factors.  This can be explained, in part, by recurring dis-
cussions with providers early in the project of the importance of screening for renal disease in 
diabetes.  Creating awareness through informal discussions likely had a positive influence on the 
clinical decisions of providers prior to the formal implementation of the quality improvement 
project.   
The Theory of Planned Behavior was used to better understand the influences on provider 
behavior change, including attitudes and beliefs around adoption and use of clinical practice 
guidelines and guided the approach to this project.  Through this project, it was shown that in-
creasing provider knowledge of the guideline significantly improved confidence in the ability to 
perform screening for modifiable risk factors in diabetes, which translated into increases in 
screening rates.  Through application of this model, a greater understanding of the influences on 
provider behavior to use clinical practice guidelines was gained. 
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Limitations 
There were several factors that may have limited rates of provider screening.  The sample 
size of participating providers was small which creates difficulty in seeing statistically significant 
change between the pre- and post-test results of some of the parameters.  Data on screening rates 
were gathered from the number of laboratory test results received into the electronic medical    
record.  For clarity, this would reflect the number of tests completed by patients versus number of 
screening tests ordered by providers.  So, while providers may have ordered laboratory screening 
tests according to the guidelines, patient compliance, or even delay in attending the laboratory, 
may have negatively influenced the calculations of rates of screening.  It is entirely possible that 
provider rates of screening could have been much higher.  The duration of the project may also 
have limited findings in that laboratory measures relevant to this project are usually repeated 
every two to three months and may not have been captured in the short span of the project.  As 
well, the recommended time-to-appointment for diabetic patients is generally three months and 
this may not have been enough time to allow for patients to attend for follow-up and potential 
repeat laboratory testing. 
Implications for Clinical Practice 
As with any quality improvement project, it is hoped that the change in clinical practice 
will be enduring and lead to improved outcomes for all patients.  It is anticipated that the pro-
vider knowledge gained from participating in this project will translate into use in the general pa-
tient population, most whom are seniors with multiple chronic conditions, including hyperten-
sion and diabetes.  It is hoped that provider awareness and confidence resulting from this project 
will have a lasting effect on the general health of all patients.   
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Conclusion 
The importance of quality initiatives to improve diabetes management via primary care 
clinics cannot be overstated yet remains a challenge for providers.  Globally, early detection, 
through projects such as this, include the potential for positive behavioral change in providers by 
creating awareness of the risk of renal disease through dialogue and education.  Increasing pro-
vider knowledge and awareness of CPGs specific to screening for CKD in diabetes provides a 
fitting framework for continuous quality improvement through the evaluation of provider pro-
cesses on patient outcomes.  This project demonstrates that a relatively simple quality improve-
ment project aimed at enhancing provider knowledge and awareness of clinical practice guide-
lines can improve patient outcomes.  It also shows how projects of this size and nature are both 
feasible and sustainable with very little system cost.  Projects such as this can begin to create 
awareness of the need for a defined approach to assist providers in understanding, monitoring 
and managing other chronic diseases to improve overall health outcomes for their patients.   
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Appendix A 
CDA Clinical Practice Guideline - Chronic Kidney Disease 
 
 
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2013). Canadian Diabetes Associa-
tion Clinical Practice Guidelines – Chronic Kidney disease in Diabetes.  Canadian Journal of Diabetes, 37: S129-
S136. 
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Appendix B 
Theory of Planned Behavior 
 
 
 
 
 
Ajzen, I. (1991). The Theory of Planned Behavior. Organizational Behavior and Human Decision Processes, 50(2): 
179–211. 
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Appendix C 
Primary Care Provider Pre- and Post-Questionnaire 
Questionnaire: Evaluating Primary Care Practitioners’ Confidence and Knowledge in Identifying and 
Managing Chronic Kidney Disease in Type 2 Diabetes 
 
This questionnaire is part of a student quality improvement intervention improve primary care provider 
knowledge and application of the Canadian Diabetes Clinical Practice Guideline for Screening for Chronic 
Kidney Disease in Type 2 diabetes.  All questions relate to your care approach in management of adult 
Type 2 diabetic patients. 
 
Please complete all the questions. Some questions ask about your confidence in management of Type 2 
diabetic patients with CKD; others assess knowledge of specific aspects of the guideline. 
The information provided by you is strictly confidential and will be submitted directly to the DNP stu-
dent’s advisor for coding.  You or your practice will not be identified in any reports or publications that 
may result from this study.  Respond using the following scale: 
 
1 = ‘Not at all confident’, 2 = ‘Not confident’, 3 = ‘Neither confident nor not confident’, 
4 = ‘Confident’, 5 = ‘Very confident’ 
 
 
QUESTION 
1 
Not at 
all con-
fident 
2 
Not 
confi-
dent 
3 
Neither 
confi-
dent 
nor not 
confi-
dent 
4 
Confi-
dent 
5 
Very 
Confi-
dent 
1.  How confident are you with monitoring 
eGFR in Type 2 diabetic patients? 1 2 3 4 5 
2. How confident are you at interpreting 
eGFR to stage CKD? 
1 2 3 4 5 
3. How confident are you at knowing the 
time interval for repeat testing of eGFR in 
Type 2 diabetic patients with reduced 
eGFR? 
1 2 3 4 5 
4. How confident are you in identifying sig-
nificant proteinuria in patients with Type 2 
diabetes? 
1 2 3 4 5 
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5. How confident are you at using urine 
protein results to manage Type 2 diabetes? 1 2 3 4 5 
6. How confident are you at identifying con-
ditions that can cause transient albuminu-
ria? 
1 2 3 4 5 
7. How confident are you in identifying the 
stage of nephropathy, by level of urinary al-
bumin, of Type 2 diabetic patients? 
1 2 3 4 5 
8. How confident are you in making a diag-
nosis of CKD using ACR and/or eGFR in Type 
2 diabetic patients? 
1 2 3 4 5 
9. How confident are you at knowing when 
to appropriately refer to Nephrology for 
Type 2 diabetic patients with reduced 
eGFR? 
1 2 3 4 5 
10. How confident are you at identifying 
non-diabetic causes of CKD in Type 2 dia-
betic patients? 
1 2 3 4 5 
11. How confident are you at managing hy-
pertension in Type 2 diabetic patients? 1 2 3 4 5 
12. How confident are you that you can 
achieve lowered blood pressure in Type 2 
diabetic patients?  
1 2 3 4 5 
13. How confident are you in using ACEI 
(angiotensin-converting enzyme inhibitor) 
and/or ARB (angiotensin II receptor 
blocker) medications in Type 2 diabetic pa-
tients with CKD? 
1 2 3 4 5 
14. How confident are you in using other 
anti-hypertensives in Type 2 diabetic pa-
tients with CKD? 
1 2 3 4 5 
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15. How confident are you at adjusting 
common oral medication therapies (i.e., 
gliclazide, sitagliptin, statins) in Type 2 dia-
betic patients with reduced kidney func-
tion? 
1 2 3 4 5 
16. How confident are you at initiating ther-
apy to lower lipid levels in patients with is-
chemic heart disease and Type 2 diabetes? 
1 2 3 4 5 
17. How confident are you at initiating ther-
apy to lower lipid levels in Type 2 Diabetes 
patients with CKD?  
1 2 3 4 5 
 
 
 
1. What level of Diastolic Blood pressure control do you typically aim to achieve in Type 2 diabetic pa-
tients with CKD without proteinuria?  
____________ (insert answer here) 
2. What level of Systolic Blood pressure control do you typically aim to achieve in Type 2 diabetic pa-
tients with CKD without proteinuria?  
____________ (insert answer here) 
3. What is the lowest necessary level of ACR (albumin-creatinine ratio) needed to indicate chronic kid-
ney disease? (circle one answer) 
a. > 1.0 mg/mmol 
b. > 2.0 mg/mmol 
c. > 3.0 mg/mmol 
d. > 4.0 mg/mmol 
 
4. What is the lowest necessary level of random urine ACR (albumin-creatinine ratio) with which to 
diagnose chronic kidney disease? (circle one answer) 
a. > 10 mg/mmol 
b. > 20 mg/mmol 
c. > 30 mg/mmol 
d. > 40 mg/mmol 
 
5. When the lowest random urine ACR level has been identified in a patient, what is the next recom-
mended action?  (circle one answer) 
a. order serum Cr for eGFR in 6 months AND repeat random urine ACR in 1 month 
b. order serum Cr for eGFR in 3 months AND repeat random urine ACR  twice over the next 3 months 
c. order serum Cr for eGFR in 3 months AND repeat random urine ACR twice over the next 6 months 
d. order serum Cr for eGFR in 6 months AND repeat random urine ACR in 3 months 
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6. Once the serum Cr and eGFR have been repeated, which results infer the diagnosis of chronic kidney 
disease?  circle one answer) 
a. eGFR 60-90 and 2 or more ACRs > 3.0 mg/mmol 
b. eGFR 60-90 or 2 or more ACRs > 3.0 mg/mmol 
c. eGFR <60 and 2 or more ACRs > 2.0 mg/mmol 
d. eGFR < 60 or 2 or more ACRs > 2.0 mg/mmol 
 
7. Once CKD has been diagnosed, what is the next recommended investigation? (circle one answer)) 
a. Order urine routine and microscopic (R&M) and urine dipstick immediately 
b. Order urine routine and microscopic (R&M) and urine dipstick in 3 months 
c. Order urine routine and microscopic (R&M) and urine dipstick in 6 months 
d. Order urine routine and microscopic (R&M) and urine dipstick in 12 months 
 
8. If repeat measures of serum creatinine for eGFR and random urine ACRs are now normal, when is it 
recommended to rescreen for CKD in your Type 2 diabetic patient?  
a. In 3 months 
b. In 6 months 
c. In 9 months 
d. In 12 months 
 
9. Over the past six months in my practice, I have used the Canadian Diabetes Association Clinical Prac-
tice Guideline for Chronic Kidney Disease:  
a. never 
b. 1-3 times 
c. 4-6 times 
d. 7-9 times 
e. > 10 times 
Note: 
This questionnaire was adapted, in part, from http://www.implementationscience.com/content/4/1/39.  
The complete QICKD confidence and knowledge questionnaire (QICKD-CCQ) is accessible here: 
http://www.clininf.eu/qickd_ccq 
Reference:  
Tahir, M.A., Hassan, S., de Lusignan, S. & Dmitrieva, O. (2014). Development of a questionnaire to evalu-
ate practitioners’ confidence and knowledge in primary care in managing chronic kidney disease. BMC 
Nephrology, 15(1):73. DOI: 10.1186/1471-2369-15-73. 
 
  
PRIMARY CARE PROVIDER ADHERENCE                                                                  35  
 
Appendix D 
Provider Toolkit: Executive Summary – Chronic Kidney Disease in Diabetes 
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Provider Toolkit: Screening for CKD Algorithm 
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Provider Toolkit: 2015 Interim Update 
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Provider Toolkit: Therapeutic Considerations in Renal Impairment
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Provider Toolkit: 2016 Nova Scotia Renal Program Guidelines
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Provider Toolkit: Patient Information Brochure 
 
Reference: The Kidney Foundation of Canada (2009). Diabetes and Kidney Disease [Brochure]. Montreal, QC. Author. 
